139 related articles for article (PubMed ID: 15959415)
1. An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives.
Monnier L; Benichou M; Charra-Ebrard S; Boegner C; Colette C
Diabetes Metab; 2005 Apr; 31(2):101-9. PubMed ID: 15959415
[TBL] [Abstract][Full Text] [Related]
2. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.
Woerle HJ; Neumann C; Zschau S; Tenner S; Irsigler A; Schirra J; Gerich JE; Göke B
Diabetes Res Clin Pract; 2007 Aug; 77(2):280-5. PubMed ID: 17240473
[TBL] [Abstract][Full Text] [Related]
3. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
Bonora E
Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
[TBL] [Abstract][Full Text] [Related]
4. Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications.
Monnier L; Colette C
Diabetes Metab; 2015 Dec; 41(6 Suppl 1):6S9-6S15. PubMed ID: 26774019
[TBL] [Abstract][Full Text] [Related]
5. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
Giugliano D; Ceriello A; Razzoli E; Esposito K
Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Fasting Versus Postprandial Plasma Glucose with HbA1c in Chinese Type 2 Diabetic Patients Taking Different Hypoglycemic Agents.
Wang X; Wang F; Wang H; Li N
Clin Lab; 2017 Jul; 63(7):1293-1300. PubMed ID: 28792708
[TBL] [Abstract][Full Text] [Related]
7. Relationship between HbA1c and indices of glucose tolerance derived from a standardized meal test in newly diagnosed treatment naive subjects with Type 2 diabetes.
Peter R; Luzio SD; Dunseath G; Pauvaday V; Mustafa N; Owens DR
Diabet Med; 2006 Sep; 23(9):990-5. PubMed ID: 16922705
[TBL] [Abstract][Full Text] [Related]
8. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.
Avignon A; Radauceanu A; Monnier L
Diabetes Care; 1997 Dec; 20(12):1822-6. PubMed ID: 9405900
[TBL] [Abstract][Full Text] [Related]
9. Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: variations with levels of HbA1c.
Kikuchi K; Nezu U; Shirakawa J; Sato K; Togashi Y; Kikuchi T; Aoki K; Ito Y; Kimura M; Terauchi Y
Endocr J; 2010; 57(3):259-66. PubMed ID: 20086313
[TBL] [Abstract][Full Text] [Related]
10. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
11. Postprandial glucose regulation: new data and new implications.
Leiter LA; Ceriello A; Davidson JA; Hanefeld M; Monnier L; Owens DR; Tajima N; Tuomilehto J;
Clin Ther; 2005; 27 Suppl B():S42-56. PubMed ID: 16519037
[TBL] [Abstract][Full Text] [Related]
12. Relative contribution of basal and postprandial hyperglycaemia stratified by HbA1c categories before and after treatment intensification with dulaglutide.
Umpierrez G; Pantalone KM; Atisso CM; Landó LF; Patel H
Diabetes Obes Metab; 2019 Jun; 21(6):1365-1372. PubMed ID: 30756511
[TBL] [Abstract][Full Text] [Related]
13. Targeting prandial hyperglycemia: how important is it and how best to do this?
Monnier L; Colette C
Curr Diab Rep; 2008 Oct; 8(5):368-74. PubMed ID: 18778585
[TBL] [Abstract][Full Text] [Related]
14. HbA1c levels are better predicted by prebreakfast than postbreakfast blood glucose self-analyses in type 2 diabetes. Influence of duration of diabetes and mode of treatment.
Relimpio F; Guerrero R; Martínez-Brocca MA
Acta Diabetol; 2007 Jun; 44(2):55-9. PubMed ID: 17530467
[TBL] [Abstract][Full Text] [Related]
15. Do glycoalbumin levels preferentially reflect changes in postprandial glucose excursions?
Paul SK; Holman RR
Diabet Med; 2017 Sep; 34(9):1284-1290. PubMed ID: 28477414
[TBL] [Abstract][Full Text] [Related]
16. What are the preferred strategies for control of glycaemic variability in patients with type 2 diabetes mellitus?
Zenari L; Marangoni A
Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():17-25. PubMed ID: 24034516
[TBL] [Abstract][Full Text] [Related]
17. Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes.
Christiansen JS; Vaz JA; Metelko Z; Bogoev M; Dedov I
Diabetes Obes Metab; 2003 Nov; 5(6):446-54. PubMed ID: 14617231
[TBL] [Abstract][Full Text] [Related]
18. Contributions of fasting and postprandial glucose to hemoglobin A1c.
Monnier L; Colette C
Endocr Pract; 2006; 12 Suppl 1():42-6. PubMed ID: 16627379
[TBL] [Abstract][Full Text] [Related]
19. Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients.
Sun J; Dou JT; Wang XL; Yang GQ; Lü ZH; Zheng H; Ma FL; Lu JM; Mu YM
Chin Med J (Engl); 2011 Nov; 124(22):3641-5. PubMed ID: 22340217
[TBL] [Abstract][Full Text] [Related]
20. Glycaemic instability is an underestimated problem in Type II diabetes.
Praet SF; Manders RJ; Meex RC; Lieverse AG; Stehouwer CD; Kuipers H; Keizer HA; van Loon LJ
Clin Sci (Lond); 2006 Aug; 111(2):119-26. PubMed ID: 16613586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
